Miao Hui, Li Da-Qiang, Mukherjee Amitava, Guo Hong, Petty Aaron, Cutter Jennifer, Basilion James P, Sedor John, Wu Jiong, Danielpour David, Sloan Andrew E, Cohen Mark L, Wang Bingcheng
Department of Medicine, Rammelkamp Center for Research, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Cancer Cell. 2009 Jul 7;16(1):9-20. doi: 10.1016/j.ccr.2009.04.009.
Both pro- and antioncogenic properties have been attributed to EphA2 kinase. We report that a possible cause for this apparent paradox is diametrically opposite roles of EphA2 in regulating cell migration and invasion. While activation of EphA2 with its ligand ephrin-A1 inhibited chemotactic migration of glioma and prostate cancer cells, EphA2 overexpression promoted migration in a ligand-independent manner. Surprisingly, the latter effects required phosphorylation of EphA2 on serine 897 by Akt, and S897A mutation abolished ligand-independent promotion of cell motility. Ephrin-A1 stimulation of EphA2 negated Akt activation by growth factors and caused EphA2 dephosphorylation on S897. In human astrocytoma, S897 phosphorylation was correlated with tumor grades and Akt activation, suggesting that the Akt-EphA2 crosstalk may contribute to brain tumor progression.
EphA2激酶兼具促癌和抑癌特性。我们报道,这一明显矛盾现象的一个可能原因是EphA2在调节细胞迁移和侵袭中发挥着截然相反的作用。用其配体ephrin-A1激活EphA2会抑制胶质瘤和前列腺癌细胞的趋化迁移,而EphA2的过表达则以不依赖配体的方式促进迁移。令人惊讶的是,后一种效应需要Akt将EphA2的丝氨酸897磷酸化,而S897A突变消除了不依赖配体的细胞运动促进作用。Ephrin-A1对EphA2的刺激会抵消生长因子对Akt的激活,并导致EphA2在S897位点去磷酸化。在人类星形细胞瘤中,S897磷酸化与肿瘤分级和Akt激活相关,这表明Akt-EphA2的相互作用可能促进脑肿瘤进展。